ArticleJournal of Taibah University Medical Sciences2026
Frequency and comorbidities of age-related macular degeneration in KSA: A retrospective multiregional study.
Article in Journal of Taibah University Medical Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly. In this study, we characterized the frequency of AMD and its comorbidities in understudied regions. Methods: A retrospective cohort study was conducted using medical records from tertiary care hospitals in KSA (2016-2022). Patients aged ≥40 years with a confirmed AMD diagnosis were included. Demographic and clinical data were analyzed, including comorbidities. Logistic regression analyses were performed. Results: Among the 335 patients diagnosed, 66.9% had the exudative form and 33.1% had the non-exudative form. The cohort had a mean age of 71.17 ± 10.12 years, and there was no significant difference in age between AMD subtypes ( Conclusion: Our findings highlight the burden of AMD and its comorbidities in KSA. Diabetes and stroke are key predictors, demonstrating the need for integrated chronic disease management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.